ARCHIVES

Biotech Firm Plans Custom Clinical trials In USSR for Drug Firms

This article is from The Cancer Letter archive.

Vol. 15 No. 33 | August 18, 1989

Download PDF Visit The Full Archive

Related Articles

GAO Study Claiming No Benefit Seen In Adjuvant Breast Cancer Treatment Flawed, NCI Responds

April 21, 1989

Board Commends M.D. Anderson On 50th Year

May 17, 1991

House-Senate Conferees Approve $6 Million Centers Amendment to Supplemental Appropriations Bill

June 27, 1986

Bristol-Myers Adds UCLA, Fox Chase To Grants Program

April 12, 1985

Also FDA clarifies data requirements for phase I IND applications.

April 29, 2005

55 NCI Grantees Win Shannon Awards, NCI gets $5.2 Mil.

October 4, 1991